Cargando…
Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
BACKGROUND: Genomic techniques in recent years have allowed the identification of many mutated genes important in the pathogenesis of acute myeloid leukemia (AML). Together with cytogenetic aberrations, these gene mutations are powerful prognostic markers in AML and can be used to guide patient mana...
Autores principales: | Au, Chun Hang, Wa, Anna, Ho, Dona N., Chan, Tsun Leung, Ma, Edmond S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722624/ https://www.ncbi.nlm.nih.gov/pubmed/26796102 http://dx.doi.org/10.1186/s13000-016-0456-8 |
Ejemplares similares
-
BAMClipper: removing primers from alignments to minimize false-negative mutations in amplicon next-generation sequencing
por: Au, Chun Hang, et al.
Publicado: (2017) -
INDELseek: detection of complex insertions and deletions from next-generation sequencing data
por: Au, Chun Hang, et al.
Publicado: (2017) -
Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results
por: Yuce Kahraman, Cigdem, et al.
Publicado: (2022) -
Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms
por: Bartels, Stephan, et al.
Publicado: (2016) -
Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)